Do you qualify for compensation? Find Out Now (30-second survey)

Ambien Tied to Alzheimers

Ambien Tied to Alzheimer’s – What They Knew, When They Knew It

Insomnia is a difficult condition that impacts all areas of your life. Not being able to fall asleep or stay asleep can leave you feeling tired, cranky and makes it hard to think clearly. Ambien may have seemed like a good choice to get you that much needed rest, but now many studies are showing that there is a clear link between Ambien and Alzheimer’s disease.

What They Knew

Ambien (zolpidem) was approved by the FDA in 1992. Since this medication has been on the market for a while, there have been several studies conducted showing the long term effects on patients and one of the biggest concerns involves the increased risk of dementia and Alzheimer’s. For example, one study published in the British Medical Journal (BMJ) found that patients who had more than 91 doses of benzodiazepine were 50% more likely to be diagnosed with Alzheimer’s over the following six years than those who took less doses. (Ambien is classified as nonbenzodiazepine, but while their molecular composition is different, they modulate GABA receptors in the brain binding to the benzodiazepine site therefore creating similar results and risks.)

An additional study took place in Taiwan where scientists monitored the health records of newly diagnosed dementia patients 65 years and older. They stated that, “Zolpidem alone or with other underlying diseases, such as hypertension, diabetes, and stroke, was significantly associated with dementia.”

A third study was published in the journal JAMA Internal Medicine and researchers analyzed 3,434 men and women aged 65 and over for around seven years. They discovered that those who were taking anticholinergic drug increased their risk of developing Alzheimer’s by 63%.

When They Knew It

These studies took place in 2014, 2015 and 2015, respectively. However, even with the evidence supporting the fact that there is a definite link between Ambien and Alzheimer’s, there is no warning to educate doctors and patients about the possibility of the increased risk of dementia associated with this medication. Moreover, Ambien is one of the most prescribed drugs in America (it was #12 in 2016), so this danger inevitably impacts millions of patients.

What Can You Do?

If you or a loved one took Ambien after 1992 and was diagnosed with Alzheimer’s, you may be eligible for compensation. You possibly have accumulated high medical bills for the additional care needed or you might have had to quit your job to take care of a loved one. Contact us today to see if we’re able to help you make a claim.

Ambien Warnings In The News

12/20/17: FDA Report: Ambien and Dementia

Dementia is found among people who take Ambien, especially for people who are female, 60+ old, have been taking the drug for 1 – 6 months, also take medication Lisinopril, and have Osteoporosis. This review analyzes which people have Dementia with Ambien. It is created by eHealthMe based on reports of 62,274 people who have side effects when taking Ambien from FDA, and is updated regularly.

Read Full Article

4/4/16: Do Sleeping Pills Increase the Risk of Dementia?

One of the great health worries of our modern times is Alzheimer’s disease. Many think it’s genetic, but what if some sleeping pills contribute to dementia?

Although heart disease and cancer remain our big killers, nothing spells dread more than a diagnosis of dementia. Losing the ability to think, remember or function is devastating to the individual as well as to friends and family. That’s why this reader’s question about sleeping pills is so poignant…

Read Full Article

5/1/15: An Increased Risk of Reversible Dementia May Occur After Zolpidem Derivative Use in the Elderly Population

We evaluate the effects of zolpidem use to develop dementia or Alzheimer disease from the Taiwan National Health Insurance Research Database (NHIRD). A retrospective population-based nested case-control study. Newly diagnosed dementia patients 65 years and older and controls were sampled. A total of 8406 dementia and 16,812 control subjects were enrolled from Taiwan NHIRD during 2006 to 2010.

The relationships between zolpidem use and dementia were measured using odds and adjusted odds ratios. The relationship between the average cumulative doses for zolpidem and dementia was also analyzed. Zolpidem used might be associated with increased risk for dementia in elderly population. Increased accumulative dose might have higher risk to develop dementia, especially in patients with underlying diseases such as hypertension, diabetes, and stroke.

Read Full Article

1/26/15: Study Suggests Sleeping Drugs Can Increase Risk of Alzheimer’s

Over-the-counter sleeping aids and hayfever treatments can increase the risk of Alzheimer’s disease, a study has found. The sleeping medication Nytol and anti-allergy pills Benadryl and Piriton all belong to a class of drug highlighted in a warning from researchers.

Each of these drugs has “anticholinergic” blocking effects on the nervous system that are said – at higher doses – to raise the likelihood of developing Alzheimer’s and other forms of dementia significantly over several years.

Read Full Article

GET YOUR FREE Ambien CASE REVIEW TODAY

Ambien settlements are now being negotiated, but there is a limited window to pursue help. If you think you, a friend, or a family member may qualify, get your free case review today… before it’s too late!

  • * Submit now to learn if you may be eligible for a cash settlement or call (800) 511-3838 now.

Free Guide Download

The Step-By-Step Guide To Taking Action

How to File for Financial Settlement After Injury from an Unsafe Drug or Device

Free Guide Download

The Step-By-Step Guide To Taking Action

How to File for Financial Settlement After Injury from an Unsafe Drug or Device

LATEST ARTICLES

FDA Adverse Effect Reporting System and Why it Doesn’t Work

It can be really scary to take a medication and read about the possible dangerous side effects that could happen. However, many times there could be other frightening side effects or harmful drug interactions that weren’t made evident in the pre-market testing. This is why it’s important to report to the FDA if you’re experiencing problems that weren’t listed in the packet that came with your medication. However, reporting drug and device problems to the FDA isn’t an easy process and could be allowing potentially unsafe drugs and medical devices to put others in harm’s way.

(more…)

Periscope Group is not owned by or operated on behalf of any attorney or law firm. We are not affiliated with any drug or medical device companies. We do not host advertisements nor do we accept advertising requests. We are here to help YOU, the consumer, become better educated and supported. You pay absolutely nothing for our help. It’s as simple as that.

Periscope Group is not owned by or operated on behalf of any attorney or law firm. We are not affiliated with any drug or medical device companies. We do not host advertisements nor do we accept advertising requests. We are here to help YOU, the consumer, become better educated and supported. You pay absolutely nothing for our help. It’s as simple as that.

HON Code Certification

© All Rights Reserved • 2017 • Periscope Group, 4155 Blackhawk Plaza Circle, Suite 100, Danville, CA 94506 Legal Disclaimer

Protected by Copyscape

© All Rights Reserved • 2017 • Periscope Group, 4155 Blackhawk Plaza Circle, Suite 100, Danville, CA 94506 Legal Disclaimer

HON Code Certification